Safety and immunogenicity profiles of an adjuvanted seasonal influenza vaccine in Guatemalan children | Zendy

Adib Rodriguez Solares | Zendy; Carlos Grazioso Aragon | Zendy; Rodolfo Urruela Pivaral | Zendy; David Prado-Cohrs | Zendy; Victor Sales-Carmona | Zendy; Michele Pellegrini | Zendy; Nicola Groth | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Safety and immunogenicity profiles of an adjuvanted seasonal influenza vaccine in Guatemalan children

Author(s) -

Adib Rodriguez Solares,

Carlos Grazioso Aragon,

Rodolfo Urruela Pivaral,

David Prado-Cohrs,

Victor Sales-Carmona,

Michele Pellegrini,

Nicola Groth

Publication year - 2014

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.4594

Subject(s) - medicine , immunogenicity , adverse effect , influenza vaccine , vaccination , titer , trivalent influenza vaccine , hemagglutination assay , immunology , live attenuated influenza vaccine , antibody , antibody titer , virology

The efficacy of non-adjuvanted seasonal influenza vaccine in young children is considered to be suboptimal. This study compared the safety and immunogenicity profiles of MF59-adjuvanted, trivalent, influenza vaccine (ATIV) and non-adjuvanted, trivalent, influenza vaccine (TIV) in Guatemalan children (N = 360) between 6 and < 60 months of age.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research